Amend the Controlled Substances Act to schedule MGM-15, MGM-16, synthetic 7-hydroxymitragynine, and Mitragynine Pseudoindoxyl as Schedule I controlled substances above specified thresholds, and expand enforcement against manufacturers and distributors of emerging synthetic opioids known as gas station heroin.

Lance Gooden · Texas · Republican

policy impact 0.78 specificity 0.95 extraction confidence 97%

Commitment kind: action. Promised action: Amend the Controlled Substances Act to schedule MGM-15, MGM-16, synthetic 7-hydroxymitragynine, and Mitragynine Pseudoindoxyl as Schedule I controlled substances above specified thresholds and expand enforcement actions against manufacturers and distributors of emerging synthetic opioids.. Promised outcome: not established. Deadline: unknown; not assumed expired. H.R. 10272, the End Gas Station Heroin Act, introduced in the U.S. House in the 119th Congress on September 3, 2026 by Rep. Lance Gooden of Texas.

Contest this claim

Occurrences

To amend the Controlled Substances Act to schedule MGM–15 and MGM–16 as Schedule I Controlled substances, and to amend the controlled Substances Act to schedule synthetic 7-hydroxymitragynine, and Mitragynine Pseudoindoxyl, as a Schedule I above a specific threshold under the Controlled Substances Act, and to expand enforcement actions against drug manufacturers and distributors of emerging synthetic opioids, commonly known as gas station heroin.

Gooden introduced the End Gas Station Heroin Act, which proposes scheduling specified synthetic opioid-related substances under the Controlled Substances Act and expanding enforcement against manufacturers and distributors.

H.R. 10272 (IH) - End Gas Station Heroin Act - BILLS-119hr10272ih | Related Documents | GovInfo
primary · other · model gpt-5.5

Full Title To amend the Controlled Substances Act to schedule MGM–15 and MGM–16 as Schedule I Controlled substances, and to amend the controlled Substances Act to schedule synthetic 7-hydroxymitragynine, and Mitragynine Pseudoindoxyl, as a Schedule I above a specific threshold under the Controlled Substances Act, and to expand enforcement actions against drug manufacturers and distributors of emerging synthetic opioids, commonly known as gas station heroin.

Gooden introduced H.R. 10272, a bill to schedule specified emerging synthetic opioid substances under the Controlled Substances Act and expand enforcement against related manufacturers and distributors.

H.R. 10272 (IH) - End Gas Station Heroin Act - BILLS-119hr10272ih | Content Details | GovInfo
primary · other · model gpt-5.5

Evidence

unverified · Source version 60569 · locator unknown

GovInfo lists the last action date as September 3, 2026: Mr. Gooden introduced H.R. 10272 and it was referred to the House Energy and Commerce and Judiciary Committees. The full title says the bill would amend the Controlled Substances Act to schedule MGM-15, MGM-16, synthetic 7-hydroxymitragynine, and Mitragynine Pseudoindoxyl above a threshold, and expand enforcement against emerging synthetic opioids known as gas station heroin.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Gooden introduced legislation matching the commitment, but the official record shows only introduction and committee referral, not enactment or final amendment of the CSA. No later official action is shown in this record as of the refresh.

unresolved same_term A for effort

H.R. 10272 (IH) - End Gas Station Heroin Act - BILLS-119hr10272ih | Content Details | GovInfo
primary · model gpt-5.5 · confidence 96%

Contest this evidence item

legacy_unverified · Source version not recorded · locator unknown

DOJ announced emergency scheduling of mitragynine pseudoindoxyl, MGM-15, and MGM-16. It said DEA was temporarily placing the three 7-hydroxymitragynine-related substances in Schedule I of the Controlled Substances Act and that the action subjects manufacture, distribution, and possession to Schedule I regulatory controls and administrative, civil, and criminal sanctions. DOJ also stated the policy does not change the scheduling status of any other substance.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Executive action partially achieved the scheduling/enforcement goal for MGPI, MGM-15, and MGM-16, but it was temporary agency scheduling rather than Gooden's statutory amendment and did not complete scheduling for synthetic 7-hydroxymitragynine above thresholds.

partial same_term

Justice Department Announces Emergency Scheduling of Three Potent Opioid Compounds
secondary · model gpt-5.5 · confidence 90%

Contest this evidence item

Assessments

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): partial. same_term A for effort

Gooden introduced H.R. 10272, which closely matches the promised statutory amendment, but the bill has only been introduced and referred to committees, so the Controlled Substances Act has not been amended as promised. DOJ separately used emergency scheduling to place MGM-15, MGM-16, and mitragynine pseudoindoxyl under temporary Schedule I controls with related enforcement consequences, which partially advances the substance-control goal but does not enact Gooden's bill, does not complete the full statutory threshold framework, and does not cover synthetic 7-hydroxymitragynine as promised. Credit is therefore partial, with an effort badge for Gooden's serious legislative attempt.

provider codex_cli · model gpt-5.5 · confidence 92%